Article
Detection of Mycobacterium tuberculosis pncA Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional Sequencing.
Antimicrobial agents and chemotherapy - 1 Jan 2018
Willby Melisa J, Wijkander Maria, Havumaki Joshua, Johnson Kartee, Werngren Jim, Hoffner Sven, Denkinger Claudia M, Posey James E
Abstract excerpt
Pyrazinamide (PZA) is a standard component of first-line treatment regimens for Mycobacterium tuberculosis and is included in treatment regimens for drug-resistant M. tuberculosis whenever possible. Therefore, it is imperative that susceptibility to PZA be assessed reliably prior to the initiation of therapy. Currently available growth-based PZA susceptibility tests are time-consuming, and results can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
